{"organizations": [], "uuid": "cb36c48769eb63c290b8e4539c1884a9a34b5618", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180507.html", "section_title": "Archive News &amp; Video for Monday, 07 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-auris-medical-receives-positive-sc/brief-auris-medical-receives-positive-scientific-advice-from-ema-on-development-plan-and-regulatory-pathway-for-am-111-idUSFWN1SE0DR", "country": "US", "domain_rank": 408, "title": "Auris Medical Receives Positive Scientific Advice From EMA On Development Plan And Regulatory Pathway For AM-111", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.345, "site_type": "news", "published": "2018-05-07T19:33:00.000+03:00", "replies_count": 0, "uuid": "cb36c48769eb63c290b8e4539c1884a9a34b5618"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-auris-medical-receives-positive-sc/brief-auris-medical-receives-positive-scientific-advice-from-ema-on-development-plan-and-regulatory-pathway-for-am-111-idUSFWN1SE0DR", "ord_in_thread": 0, "title": "Auris Medical Receives Positive Scientific Advice From EMA On Development Plan And Regulatory Pathway For AM-111", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "auris medical holding ag", "sentiment": "negative"}, {"name": "ema on development plan", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 7 (Reuters) - Auris Medical Holding AG:\n* AURIS MEDICAL RECEIVES POSITIVE SCIENTIFIC ADVICE FROM EMA ON DEVELOPMENT PLAN AND REGULATORY PATHWAY FOR AM-111\n* AURIS MEDICAL HOLDING AG - DESIGN FOR SINGLE PIVOTAL PHASE 3 TRIAL VALIDATED BY EUROPEAN MEDICINES AGENCY\n* AURIS MEDICAL - INTENDS TO PROVIDE UPDATE ON PLANS FOR ADVANCING AM-111 DEVELOPMENT PROGRAM AS PART OF A GENERAL STRATEGY UPDATE ON MAY 15 Source text for Eikon:\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-07T19:33:00.000+03:00", "crawled": "2018-05-08T16:30:29.066+03:00", "highlightTitle": ""}